New boronate drugs and evolving NDM-mediated beta-lactam resistance
Antimicrobial Agents and Chemotherapy · 19.09.2023 · 67 (9)
DOI: 10.1128/aac.00579-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 19.09.2023. Verfasst von Olga Lomovskaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Qpex Biopharma, Inc. , San Diego, California, USA. Hauptthemen laut MEDLINE: Borinic Acids. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | Biomedical Advanced Research and Development Authority (BARDA).
Abstract (Originalsprache)
Taniborbactam and xeruborbactam are dual serine-/metallo-beta-lactamase inhibitors (BLIs) based on a cyclic boronic acid pharmacophore that undergo clinical development. Recent report demonstrated that New Delhi metallo-beta-lactamase (NDM)-9 (differs from NDM-1 by a single amino acid substitution, E152K, evolved to overcome Zn (II) deprivation) is resistant to inhibition by taniborbactam constituting pre-existing taniborbactam resistance mechanism. Using microbiological and biochemical experiments, we show that xeruborbactam is capable of inhibiting NDM-9 and propose the structural basis for differences between two BLIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qpex Biopharma, Inc. , San Diego, California, USA.
- Molsoft, LLC , San Diego, California, USA.
- IHMA, Inc. , Schaumburg, Illinois, USA.
- JMI Laboratories , North Liberty, Iowa, USA.
ORCID-Profile: Olga Lomovskaya
Förderung
- HHS | Biomedical Advanced Research and Development Authority (BARDA)
Zitieren
APA
Lomovskaya, O., Tsivkovski, R., Totrov, M., Dressel, D., Castanheira, M., & Dudley, M. (2023). New boronate drugs and evolving NDM-mediated beta-lactam resistance. Antimicrobial Agents and Chemotherapy, 67(9). https://doi.org/10.1128/aac.00579-23
Vancouver
Lomovskaya O, Tsivkovski R, Totrov M, Dressel D, Castanheira M, Dudley M. New boronate drugs and evolving NDM-mediated beta-lactam resistance. Antimicrobial Agents and Chemotherapy. 2023;67(9). doi:10.1128/aac.00579-23
BibTeX
@article{Lomovskaya2023,
author = {Lomovskaya, Olga and Tsivkovski, Ruslan and Totrov, Maxim and Dressel, Dana and Castanheira, Mariana and Dudley, Michael},
title = {New boronate drugs and evolving NDM-mediated beta-lactam resistance},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {9},
doi = {10.1128/aac.00579-23}
}
EUVIMED